Literature DB >> 10571728

Absorption of hyaluronan applied to the surface of intact skin.

T J Brown1, D Alcorn, J R Fraser.   

Abstract

Hyaluronan has recently been introduced as a vehicle for topical application of drugs to the skin. We sought to determine whether hyaluronan acts solely as a hydrophilic reservoir on the surface of intact skin or might partly penetrate it. Drug-free hyaluronan gels were applied to the intact skin of hairless mice and human forearm in situ, with and without [3H] hyaluronan. [3H]hyaluronan was shown by autoradiography to disseminate through all layers of intact skin in mouse and human, reaching the dermis within 30 min of application in mice. Cellular uptake of [3H]hyaluronan was observed in the deeper layers of epidermis, dermis, and in lymphatic endothelium. Absorption through skin was confirmed in mice by chromatographic analysis of blood, urine, and extracts from skin and liver, which identified 3H as intact hyaluronan and its metabolites, free acetate and water. Hyaluronan absorption was similarly demonstrated without polyethylene glycol, which is usually included in the topical formulation. [3H]hyaluronan absorption was not restricted to its smaller polymers as demonstrated by the recovery of polymers of (360-400 kDa) from both blood and skin. This finding suggests that its passage through epidermis does not rely on passive diffusion but may be facilitated by active transport. This study establishes that hyaluronan is absorbed from the surface of the skin and passes rapidly through epidermis, which may allow associated drugs to be carried in relatively high concentration at least as far as the deeper layers of the dermis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571728     DOI: 10.1046/j.1523-1747.1999.00745.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

1.  Size selectivity of hyaluronan molecular sieving by extracellular matrix in rabbit synovial joints.

Authors:  S Sabaratnam; V Arunan; P J Coleman; R M Mason; J R Levick
Journal:  J Physiol       Date:  2005-06-16       Impact factor: 5.182

2.  Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.

Authors:  Ming Chen; Vivek Gupta; Aaron C Anselmo; John A Muraski; Samir Mitragotri
Journal:  J Control Release       Date:  2013-10-12       Impact factor: 9.776

3.  Optical clearing of skin enhanced with hyaluronic acid for increased contrast of optoacoustic imaging.

Authors:  Anton Liopo; Richard Su; Dmitri A Tsyboulski; Alexander A Oraevsky
Journal:  J Biomed Opt       Date:  2016-08       Impact factor: 3.170

4.  Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction.

Authors:  Lilly Y W Bourguignon; Gabriel Wong; Weiliang Xia; Mao-Qiang Man; Walter M Holleran; Peter M Elias
Journal:  J Dermatol Sci       Date:  2013-06-05       Impact factor: 4.563

5.  Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant.

Authors:  Ki Su Kim; Hyemin Kim; Yunji Park; Won Ho Kong; Seung Woo Lee; Sheldon J J Kwok; Sei Kwang Hahn; Seok Hyun Yun
Journal:  Adv Funct Mater       Date:  2016-02-01       Impact factor: 18.808

6.  Enhanced efficacy of a facial hydrating serum in subjects with normal or self-perceived dry skin.

Authors:  W Philip Werschler; Nathan S Trookman; Ronald L Rizer; Elizabeth T Ho; Rahul Mehta
Journal:  J Clin Aesthet Dermatol       Date:  2011-02

7.  Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.

Authors:  Martin A C Manoukian; Susanne V Ott; Jayakumar Rajadas; Mohammed Inayathullah
Journal:  Recent Pat Nanomed       Date:  2014

Review 8.  Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions.

Authors:  Lilly Y W Bourguignon
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

9.  Filtration rate dependence of hyaluronan reflection by joint-to-lymph barrier: evidence for concentration polarisation.

Authors:  S Sabaratnam; R M Mason; J R Levick
Journal:  J Physiol       Date:  2004-04-08       Impact factor: 5.182

10.  Development of a hyaluronan bioconjugate for the topical treatment of melanoma.

Authors:  Li-Shu Zhang; Henry J Greyner; Mark E Mummert; W Matthew Petroll
Journal:  J Dermatol Sci       Date:  2009-04-05       Impact factor: 4.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.